Tandem Diabetes Care (NASDAQ:TNDM) Given New $59.00 Price Target at Canaccord Genuity Group
Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price target hoisted by Canaccord Genuity Group from $58.00 to $59.00 in a report published on Thursday morning,Benzinga reports. They currently have a buy rating on the medical device company’s stock. A number of other research analysts also recently commented on the stock. Piper Sandler dropped […]
Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price target hoisted by Canaccord Genuity Group from $58.00 to $59.00 in a report published on Thursday morning,Benzinga reports. They currently have a buy rating on the medical device company’s stock. A number of other research analysts also recently commented on the stock. Piper Sandler dropped […]
